LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|DCIS|Invasive Duct Carcinoma of Breast
Interventions: DRUG: LS301-IT 0.025 mg/kg|DRUG: LS301-IT 0.05 mg/kg|DRUG: LS301-IT 0.075 mg/kg|DRUG: LS301-IT 0.1 mg/kg
Sponsor: Integro Theranostics